United Therapeutics Corp. | Mutual Funds
Mutual Funds that own United Therapeutics Corp.
Fidelity Series Intrinsic Opportunities Fund
2,000,000
4.59%
0
1.9%
04/30/2018
iShares Core S&P Mid Cap ETF
1,189,827
2.73%
960
0.28%
09/06/2018
Vanguard Small Cap Index Fund
1,040,820
2.39%
13,324
0.13%
07/31/2018
Vanguard Total Stock Market Index Fund
1,039,661
2.39%
1,058
0.02%
07/31/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
689,574
1.58%
689,574
0.02%
03/31/2018
SPDR S&P Biotech ETF
655,779
1.51%
1,686
1.38%
09/06/2018
Vanguard Small Cap Value Index Fund
654,177
1.5%
6,841
0.25%
07/31/2018
Old Mutual Global Equity Absolute Return Fund
653,428
1.5%
151,041
0.79%
09/29/2017
First Trust NYSE Arca Biotechnology Index Fund
592,375
1.36%
0
3.14%
09/05/2018
Vanguard Extended Market Index Fund
574,653
1.32%
3,590
0.1%
07/31/2018
| Address |
1040 Spring Street
Silver Spring Maryland 20910
United States
|
|
Employees
|
- |
| Website |
http://www.unither.com |
| Updated |
07/08/2019 |
| United Therapeutics Corp. biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. |
